Publications by the researcher in collaboration with Víctor Valentí Azcarate (16)

2024

  1. Decreased expression of the NLRP6 inflammasome is associated with increased intestinal permeability and inflammation in obesity with type 2 diabetes

    Cellular and Molecular Life Sciences, Vol. 81, Núm. 1

  2. Differential mitochondrial adaptation and FNDC5 production in brown and white adipose tissue in response to cold and obesity

    Obesity, Vol. 32, Núm. 11, pp. 2120-2134

  3. FNDC4 reduces hepatocyte inflammatory cell death via AMPKα in metabolic dysfunction-associated steatotic liver disease

    Clinical Nutrition, Vol. 43, Núm. 9, pp. 2221-2233

2023

  1. Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated nonalcoholic fatty liver disease

    European journal of endocrinology, Vol. 188, Núm. 7, pp. 564-577

  2. Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD

    Metabolism: Clinical and Experimental, Vol. 147

2022

  1. Dermatopontin Influences the Development of Obesity-Associated Colon Cancer by Changes in the Expression of Extracellular Matrix Proteins

    International Journal of Molecular Sciences, Vol. 23, Núm. 16

  2. Netrin-1 Promotes Visceral Adipose Tissue Inflammation in Obesity and Is Associated with Insulin Resistance

    Nutrients, Vol. 14, Núm. 20

  3. Serum Levels of IL-1 RA Increase with Obesity and Type 2 Diabetes in Relation to Adipose Tissue Dysfunction and are Reduced After Bariatric Surgery in Parallel to Adiposity

    Journal of Inflammation Research, Vol. 15, pp. 1331-1345

2021

  1. FNDC4 and FNDC5 reduce SARS-CoV-2 entry points and spike glycoprotein S1-induced pyroptosis, apoptosis, and necroptosis in human adipocytes

    Cellular and Molecular Immunology, Vol. 18, Núm. 10, pp. 2457-2459

  2. Obese patients with NASH have increased hepatic expression of SARS-CoV-2 critical entry points

    Journal of Hepatology

  3. Role of ANGPTL8 in NAFLD improvement after bariatric surgery in experimental and human obesity

    International Journal of Molecular Sciences, Vol. 22, Núm. 23

2017

  1. Dissociation of body mass index, excess weight loss and body fat percentage trajectories after 3 years of gastric bypass: Relationship with metabolic outcomes

    International Journal of Obesity, Vol. 41, Núm. 9, pp. 1379-1387

2015

  1. Cardiometabolic Profile Related to Body Adiposity Identifies Patients Eligible for Bariatric Surgery More Accurately than BMI

    Obesity Surgery, Vol. 25, Núm. 9, pp. 1594-1603

2012

  1. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity

    International Journal of Obesity, Vol. 36, Núm. 2, pp. 286-294

  2. Clinical usefulness of a new equation for estimating body fat

    Diabetes Care, Vol. 35, Núm. 2, pp. 383-388

2011

  1. Body adiposity and type 2 diabetes: Increased risk with a high body fat percentage even having a normal BMI

    Obesity, Vol. 19, Núm. 7, pp. 1439-1444